Lack of Influence by CYP3A4 and CYP3A5 Genotypes on Pain Relief by Hydrocodone in Postoperative Cesarean Section Pain Management

Autor: Saeed A. Jortani, Jeremy Gaskins, Tyler Yin, Keivan Hosseinnejad, Loralie L Langman, M. Elaine Stauble, Yanhong Wu, Paul J. Jannetto

Publikováno v: The Journal of Applied Laboratory Medicine. 3:954-964

Background Genetic polymorphisms of cytochrome P450 are contributors to variability in individual response to drugs. Within the P450 family, CYP2D6 is responsible for metabolizing hydrocodone, a widely prescribed opioid for pain management. Alternati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60bcc20d12ab348f8df48b0d75ecd54
https://doi.org/10.1373/jalm.2018.026070

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.

Autor: Brunet M; Pharmacology and Toxicology Laboratory, Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain., van Gelder T; Department of Internal Medicine and Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Åsberg A; Department of Transplantation Medicine, Section of Nephrology, Oslo University Hospital-Rikshospitalet, Oslo, Norway., Haufroid V; Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.; Department of Clinical Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Hesselink DA; Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Langman L; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Lemaitre F; Rennes University Hospital & INSERM, Department of Clinical and Biological Pharmacology and Pharmacovigilance, Pharmacoepidemiology and Drug Information Center, Clinical Investigation Center CIC-P 1414, Rennes, France., Marquet P; INSERM, University of Limoges, CHU Limoges, IPPRITT, U1248, Limoges, France., Seger C; Division of Mass Spectrometry and Chromatography, Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital Innsbruck, Innsbruck, Austria., Shipkova M; SYNLAB Holding Germany GmbH, Competence Center for Therapeutic Drug Monitoring, MVZ Leinfelden-Echterdingen GmbH, Stuttgart, Germany., Vinks A; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Wallemacq P; Clinical Chemistry Department, Cliniques Universitaires Saint-Luc, Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium., Wieland E; SYNLAB Holding Germany GmbH, Competence Center for Therapeutic Drug Monitoring, MVZ Leinfelden-Echterdingen GmbH, Stuttgart, Germany., Woillard JB; Department of Pharmacology and Toxicology, CHU Limoges, Limoges, France., Barten MJ; Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany., Budde K; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany., Colom H; Pharmacy and Pharmaceutical Technology and Physical Chemistry Department, University of Barcelona, Barcelona, Spain., Dieterlen MT; Department for Cardiac Surgery, Heart Center Leipzig, University of Leipzig, Leipzig, Germany., Elens L; Louvain Drug Research Institute, Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Université Catholique de Louvain, Brussels, Belgium., Johnson-Davis KL; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah., Kunicki PK; Clinical Pharmacology Unit, Department of Medical Biology, Institute of Cardiology, Warsaw, Poland.; Department of Drug Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland., MacPhee I; St George's Hospital, London, United Kingdom., Masuda S; Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan., Mathew BS; Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, India., Millán O; Pharmacology and Toxicology Laboratory, Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain., Mizuno T; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Moes DAR; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, the Netherlands., Monchaud C; Department of Pharmacology and Toxicology, CHU Limoges, Limoges, France., Noceti O; National Center for Liver Transplantation and Liver Diseases, Uruguay, South America., Pawinski T; Department of Drug Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland., Picard N; Department of Pharmacology and Toxicology, CHU Limoges, Limoges, France., van Schaik R; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands., Sommerer C; Department of Nephrology, University of Heidelberg, Heidelberg, Germany., Vethe NT; Department of Pharmacology, Oslo University Hospital, Oslo, Norway., de Winter B; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Christians U; iC42 Clinical Research and Development, Department of Anesthesiology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado., Bergan S; Department of Pharmacology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Therapeutic drug monitoring [Ther Drug Monit] 2019 Jun; Vol. 41 (3), pp. 261-307.

Continuous Glucose Monitor Interference With Commonly Prescribed Medications: A Pilot Study.

Autor: Basu A; 1 Endocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, USA., Slama MQ; 1 Endocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, USA., Nicholson WT; 2 Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA., Langman L; 3 Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Peyser T; 4 IDDM Consulting, Menlo Park, CA, USA., Carter R; 5 Department of Health Sciences Research, Mayo College, Rochester, MN, USA., Basu R; 1 Endocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, USA.

Publikováno v: Journal of diabetes science and technology [J Diabetes Sci Technol] 2017 Sep; Vol. 11 (5), pp. 936-941. Date of Electronic Publication: 2017 Mar 23.

The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.

Autor: Boswell MV; Dept. of Anesthesiology and Perioperative Medicine, University of Louisville School of Medicine, Louisville, KY, USA., Stauble ME, Loyd GE, Langman L, Ramey-Hartung B, Baumgartner RN, Tucker WW, Jortani SA

Publikováno v: Pain physician [Pain Physician] 2013 May-Jun; Vol. 16 (3), pp. E227-35.